Journal for ImmunoTherapy of Cancer (Nov 2023)

774 NeoPOWER: A phase II study of neoadjuvant PD-1 blockade with cemiplimab in high risk localized, locally recurrent and regionally advanced cutaneous squamous cell carcinoma

  • Kevin Kelly,
  • Gino K In,
  • Jeffrey Sosman,
  • Sunandana Chandra,
  • Jacob Thomas,
  • Fumito Ito,
  • Daniel Kwon,
  • Hugo Lara Martinez,
  • Erin Barrett,
  • Ashley Wysong,
  • Alissa Marr,
  • Joshua Mammen,
  • Thomas Won,
  • Anisa Sandin,
  • Sophia Marmolejo,
  • Andrew Zeng,
  • Niels Kokot,
  • Mark Swanson,
  • Denice Tsao-Wei,
  • Susan Groshen,
  • Andy Sherrod,
  • Brittney Declerck,
  • Gene Kim,
  • David Peng,
  • Jenny C Hu

DOI
https://doi.org/10.1136/jitc-2023-SITC2023.0774
Journal volume & issue
Vol. 11, no. Suppl 1

Abstract

Read online

No abstracts available.